Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) SHZ

Currency In CNY

AD

Asymchem Laboratories (Tianjin) Co., Ltd.

Address

No. 6 Dongting 3rd Street

Tianjin,

China

Phone

86 22 6638 9560

Sector

Healthcare

Industry

Biotechnology

Employees

9595

First IPO Date

November 22, 2016

Key Executives

NameTitlePayYear Born
Rui YangCo-CEO & Executive Director5.52M1977
Hao HongFounder, Chairman & Chief Executive Officer7.35M1956
Liang HongExecutive Vice President & Executive Director3.08M1974
Da ZhangChief Financial Officer, Chief Operating Officer, Senior Vice President & Executive Director5.07M1981
Xiangke XuSenior Vice President and Board Secretary of Public Affairs & Regulatory Affairs & Legal Affairs01979
Pingzhong HuangSenior Vice President of Business Development & Project Management0N/A
Yan ZhouSenior Vice President of Quality Management01979
Jiang YingweiExecutive Vice President of Human Resources & Administration01977
Elut HsuSenior Vice President of U.S. Headquarters Operations & Business Development0N/A
Changhai TianSenior Vice President of 5S Management0N/A
Chaoyong ChenExecutive Vice President of Manufacturing & Tech Transfer01982
Ching Kit ChengJoint Company Secretary01989
Guoxi ZhengSenior Vice President of EHS & UK Site Coordinator0N/A
AD

Description

Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.

AD